trending Market Intelligence /marketintelligence/en/news-insights/trending/4H6ch-Q3IDn0-sS_s22JMg2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Report: Justice Department skeptical of Aetna/Humana deal

Infrastructure Issues: Tools to Dig Deep on Potential Risks

Part Two IFRS 9 Blog Series: The Need to Upgrade Analytical Tools

2018 US Property Casualty Insurance Market Report


Fintech Funding Flows To Insurtech In February

Report: Justice Department skeptical of Aetna/Humana deal

Sharesof Humana Inc. dropped sharplyin afternoon trading July 7, amid fresh concerns that its planned with Aetna Inc. could face federal antitrust objections.

The healthinsurer's stock fell 10.70% to $160.73 as of 3:31 p.m. ET. Aetna's shares also slidthroughout the afternoon, down 4.53% to $114.79.

Antitrust-focusedpublication MLex reported the same day that the U.S. Justice Department is skepticalof the potential tie-up, which would join two of the nation's largest publicly tradedhealth insurers. Federal officials are concerned that the deal could hurt competitionwithin the industry, with Bloomberg News reportingthat they will discuss the possibility of Aetna selling some of its assets duringa July 8 meeting.

The meetingcomes soon after Justice Department officials expressedserious concerns about Anthem Inc.'smultibillion-dollar deal to acquire CignaCorp.

Humana'splanned merger with Aetna is undergoing a federal antitrust review and individualreviews in states where the deal could significantly affect their respective healthinsurance markets. The Missouri Insurance Department in May became the first stateagency to object to thedeal, finding that it would violate competitive standards.